Showing results (331-340 of 340) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 340 results.
Blood|June 1, 1997
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphomaP L Zinzani, E Pavone, S Storti, et al.
The American Journal of Pathology|September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrumB Falini, B Bigerna, M Fizzotti, et al.
Ejhaem|November 29, 2023
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemiaD Sorcini, A Stella, A Scialdone, et al.
The Histochemical Journal|November 25, 2003
Tyrosine phosphorylation in human lymphomasE Haralambieva, M Jones, G M Roncador, et al.
Leukemia|December 16, 2006
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patientsS A Pileri, S Ascani, M C Cox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphomaP L Zinzani, M Tani, A Pulsoni, et al.
Blood|June 25, 1999
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patientsP L Zinzani, S Storti, A Zaccaria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patientsP L Zinzani, F Gherlinzoni, S Storti, et al.
Blood Cancer Journal|November 11, 2014
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specifiedM A Laginestra, P P Piccaluga, F Fuligni, et al.
Histopathology|July 18, 2002
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 casesS A Pileri, T M Grogan, N L Harris, et al.
Pageof 34